SteelPeak Wealth LLC Has $821,000 Stock Holdings in Bruker Corporation $BRKR

Key Points

• SteelPeak Wealth LLC increased its holdings in Bruker Corporation by 64.3% during Q2, now owning 19,932 shares valued at approximately $821,000.
• A significant majority, 79.52%, of Bruker's stock is owned by institutional investors and hedge funds, with various firms recently adjusting their positions.
• Bruker reported Q2 earnings of $0.32 per share, missing analyst estimates, along with a revenue of $797.4 million which was also below expectations.

SteelPeak Wealth LLC grew its holdings in Bruker Corporation (NASDAQ:BRKR - Free Report) by 64.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,932 shares of the medical research company's stock after purchasing an additional 7,803 shares during the quarter. SteelPeak Wealth LLC's holdings in Bruker were worth $821,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pinnacle Bancorp Inc. acquired a new position in shares of Bruker in the 1st quarter valued at about $29,000. Allworth Financial LP lifted its stake in shares of Bruker by 92.4% in the 1st quarter. Allworth Financial LP now owns 758 shares of the medical research company's stock valued at $30,000 after purchasing an additional 364 shares during the period. Caitong International Asset Management Co. Ltd lifted its stake in shares of Bruker by 1,354.5% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company's stock valued at $33,000 after purchasing an additional 745 shares during the period. Parallel Advisors LLC lifted its stake in shares of Bruker by 63.0% in the 2nd quarter. Parallel Advisors LLC now owns 898 shares of the medical research company's stock valued at $37,000 after purchasing an additional 347 shares during the period. Finally, Annis Gardner Whiting Capital Advisors LLC acquired a new position in shares of Bruker in the 1st quarter valued at about $42,000. 79.52% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on BRKR shares. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Bruker in a research note on Wednesday. Wells Fargo & Company dropped their price target on Bruker from $60.00 to $50.00 and set an "overweight" rating on the stock in a research note on Tuesday, August 5th. Bank of America dropped their price target on Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. Jefferies Financial Group set a $60.00 price target on Bruker and gave the stock a "buy" rating in a research note on Monday, August 4th. Finally, Citigroup dropped their price target on Bruker from $40.00 to $38.00 and set a "neutral" rating on the stock in a research note on Monday, August 4th. Five analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $51.00.

Bruker Stock Performance

Shares of BRKR opened at $34.63 on Thursday. The company has a debt-to-equity ratio of 1.31, a quick ratio of 0.70 and a current ratio of 1.61. The stock has a 50 day moving average price of $33.08 and a two-hundred day moving average price of $37.31. The firm has a market capitalization of $5.25 billion, a P/E ratio of 66.60, a P/E/G ratio of 4.81 and a beta of 1.20. Bruker Corporation has a 52 week low of $28.53 and a 52 week high of $65.56.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). The company had revenue of $797.40 million for the quarter, compared to the consensus estimate of $811.17 million. Bruker had a return on equity of 17.89% and a net margin of 2.31%.The business's revenue for the quarter was down .4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.52 earnings per share. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Equities analysts forecast that Bruker Corporation will post 2.69 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 3rd. Shareholders of record on Tuesday, September 23rd were issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Tuesday, September 23rd. Bruker's payout ratio is currently 38.46%.

Insider Buying and Selling

In other Bruker news, Director Cynthia M. Friend sold 3,535 shares of the business's stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $32.25, for a total transaction of $114,003.75. Following the completion of the sale, the director directly owned 18,016 shares of the company's stock, valued at approximately $581,016. The trade was a 16.40% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 27.30% of the company's stock.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.